What Researchers Did
The researchers searched for and reviewed existing systematic reviews on treatments for osteoradionecrosis (bone damage after radiation) in adults with head and neck cancer, and rated how good those reviews and their evidence were.
What They Found
This overview of systematic reviews, covering six reviews, found critically low or moderate quality evidence that hyperbaric oxygen therapy (HBO) improves osteoradionecrosis healing, based primarily on studies from the 1990s. Since 2005, evidence has emerged on pentoxifylline and tocopherol (PENTO), and the reviews indicate PENTO appears promising. The greatest healing rates were seen in mild and moderate stages of the condition. The quality of evidence for PENTO, surgery and other treatments remains critically low, and there is no standardized treatment protocol.
What This Means for Canadian Patients
For people with osteoradionecrosis after head and neck cancer, the abstract reports that the evidence for HBO is of critically low or moderate quality and mostly dates from the 1990s. It describes PENTO as the most promising conservative treatment, though its evidence is also critically low. The abstract does not give HBO protocols such as pressure or number of sessions, so patients should discuss options with their care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The reviews it covered were of low methodological and evidence quality, with HBO evidence drawn mainly from 1990s studies, no standardized treatment protocol exists, and the authors state that more robust clinical studies are needed to establish the best treatment.